Data-driven modeling for precision medicine in pediatric acute liver failure

Molecular Medicine

Volumn 22, Issue , 2016, Pages 821-829

  Zamora, Ruben ^a,b   Vodovotz, Yoram ^a,b   Mi, Qi ^a   Barclay, Derek ^a   Yin, Jinling ^a   Horslen, Simon ^c   Rudnick, David ^d   Loomes, Kathleen M ^e   Squires, Robert H ^f  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c SEATTLE CHILDREN S HOSPITAL   (United States)

^d ST LOUIS CHILDREN S HOSPITAL   (United States)

^e CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN;

ACUTE LIVER FAILURE; ARTICLE; BAYES THEOREM; BIOASSAY; CLINICAL DECISION MAKING; CLINICAL FEATURE; CONTROLLED STUDY; HUMAN; LIVER GRAFT; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PERSONALIZED MEDICINE; SURVIVAL RATE;

EID: 85010403136     PISSN: 10761551     EISSN: 15283658     Source Type: Journal    
DOI: 10.2119/molmed.2016.00183     Document Type: Article

References (31)

1. Squires RH Jr, et al. (2006) Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J. Pediatr. 148:652-58.
2. Squires RH Jr. (2008) Acute liver failure in children. Semin. Liver Dis. 28:153-66.
3. Lee WM. (1993) Acute liver failure. New Engl. J. Med. 329:1862-72.
4. Brown KE, Tisdale J, Barrett AJ, Dunbar CE, Young NS. (1997) Hepatitis-associated aplastic anemia. New Engl. J. Med. 336:1059-64.
5. Rolando N, et al. (1990) Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology. 11:49-53.
6. Bucuvalas J, et al. (2013) Immunophenotype predicts outcome in pediatric acute liver failure. J. Pediatr. Gastroenterol. Nutr. 56:311-15.
7. Lee WM. (2003) Acute liver failure in the United States. Semin. Liver Dis. 23:217-26.
8. Kitano H. (2002) Systems biology: a brief overview. Science. 295:1662-64.
9. Vodovotz Y, Csete M, Bartels J, Chang S, An G. (2008) Translational systems biology of inflammation. PLoS Comput. Biol. 4:e1000014.
10. Vodovotz Y, Billiar TR. (2013) In silico modeling: methods and applications to trauma and sepsis. Crit. Care Med. 41:2008-14.
11. Alon U. (2007) Network motifs: theory and experimental approaches. Nat. Rev. Genet. 8:450-61.
12. Zak DE, Aderem A. (2009) Systems biology of innate immunity. Immunol. Rev. 227:264-82.
13. Gough NR, Yaffe MB. (2011) Focus issue: conquering the data mountain. Sci. Signal. 4:eg2.
14. Mi Q, et al. (2011) A dynamic view of trauma/ hemorrhage-induced inflammation in mice: principal drivers and networks. PLoS.One. 6:e19424.
15. Ziraldo C, et al. (2013) Central role for MCP-1/ CCL2 in injury-induced inflammation revealed by in vitro, in silico, and clinical studies. PLoS One. 8:e79804.
16. Almahmoud K, et al. (2015) Impact of Injury Severity on Dynamic Inflammation Networks Following Blunt Trauma. Shock. 44:101-09.
17. Almahmoud K, et al. (2015) Prehospital Hypotension Is Associated With Altered Inflammation Dynamics and Worse Outcomes Following Blunt Trauma in Humans. Crit. Care Med. 43:1395-1404.
18. Azhar N, et al. (2013) Analysis of serum inflammatory mediators identifies unique dynamic networks associated with death and spontaneous survival in pediatric acute liver failure. PLoS One. 8:e78202.
19. Sundaram V, et al. King’s College Hospital Criteria for non-acetaminophen induced acute liver failure in an international cohort of children. J. Pediatr. 162:319-23, e311.
20. Lu BR, et al. (2013) Evaluation of the liver injury unit scoring system to predict survival in a multinational study of pediatric acute liver failure. J. Pediatr. 162:1010-16, e1011-14.
21. Grzegorczyk M, Husmeier D. (2011) Improvements in the reconstruction of time-varying gene regulatory networks: dynamic programming and regularization by information sharing among genes. Bioinformatics. 27:693-99.
22. Emr B, et al. (2014) Removal of inflammatory ascites is associated with dynamic modification of local and systemic inflammation along with prevention of acute lung injury: in vivo and in silico studies. Shock. 41:317-23.
23. Zaaqoq AM, et al. (2014) Inducible protein-10, a potential driver of neurally controlled interleukin-10 and morbidity in human blunt trauma. Crit. Care Med. 42:1487-97.
24. Namas RA, et al. Temporal Patterns of Circulating Inflammation Biomarker Networks Differentiate Susceptibility to Nosocomial Infection Following Blunt Trauma in Humans. Ann. Surg. 263:191-98.
25. Tanaka R, Csete M, Doyle, J. (2005) Highly optimised global organisation of metabolic networks. Syst. Biol. (Stevenage). 152:179-84.
26. Kang R, et al. (2014) HMGB1 in health and disease. Mol. Aspects Med. 40:1-116.
27. Koniaris LG, et al. (2001) Cytokine-responsive gene-2/IFN-inducible protein-10 expression in multiple models of liver and bile duct injury suggests a role in tissue regeneration. J. Immunol. 167:399-406.
28. Bone-Larson CL, Hogaboam CM, Evanhoff H, Strieter RM, Kunkel SL. (2001) IFN-gamma-inducible protein-10 (CXCL10) is hepatoprotective during acute liver injury through the induction of CXCR2 on hepatocytes. J. Immunol. 167: 7077-83.
29. Larrubia JR, Benito-Martinez S, Calvino M, Sanz-de-Villalobos E, Parra-Cid T. (2008) Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection. World J. Gastroenterol. 14:7149-59.
30. Czaja MJ, Geerts A, Xu J, Schmiedeberg P, Ju Y. (1994) Monocyte chemoattractant protein 1 (MCP-1) expression occurs in toxic rat liver injury and human liver disease. J. Leukoc. Biol. 55:120-26.
31. Oshima G, et al. (2012) Increased plasma levels of high mobility group box 1 in patients with acute liver failure. Eur. Surg. Res. 48:154-62.